mibefradil has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gezici, A; Ozturk, H | 1 |
| Bullingham, R; Welker, HA; Wiltshire, H | 1 |
| Baylis, C; Engels, K; Qiu, C | 1 |
1 review(s) available for mibefradil and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of mibefradil.
Topics: Benzimidazoles; Calcium Channel Blockers; Cardiovascular Diseases; Drug Interactions; Food-Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Mibefradil; Tetrahydronaphthalenes | 1998 |
2 other study(ies) available for mibefradil and Kidney Diseases
| Article | Year |
|---|---|
The effects of mibefradil, a T-type Ca2+ channels blocker, on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Blood Urea Nitrogen; Calcium Channel Blockers; Creatinine; Disease Models, Animal; Immunohistochemistry; Kidney; Kidney Diseases; Kidney Function Tests; Male; Mibefradil; Nephrectomy; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Reperfusion Injury; Risk Factors; Sensitivity and Specificity | 2005 |
Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Desoxycorticosterone; Hypertension, Renovascular; Kidney Diseases; Kidney Glomerulus; Male; Mibefradil; Proteinuria; Rats; Rats, Sprague-Dawley | 2001 |